Feb 11, 2023 | ADHD, Newsletter, Telepsychiatry
The United States has experienced widespread shortages of Attention Deficit Hyperactivity Disorder (ADHD) medications in recent months, resulting in difficulties for patients who rely on these drugs to manage their conditions. In August, Adderall, a widely-used...
Jan 13, 2023 | ADHD, Anxiety, Depression, Insomnia, Newsletter
Mold is a common indoor air pollutant that can have significant health effects. Studies have suggested that mold exposure may be associated with several adverse mental health outcomes, including anxiety, attention deficit hyperactivity disorder (ADHD), depression, and...
